Changeflow GovPing Pharma & Drug Safety Pyrrole Compounds Patent - Aligos Therapeutics ...
Routine Notice Added Final

Pyrrole Compounds Patent - Aligos Therapeutics - US12599582B2

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO granted Patent US12599582B2 to Aligos Therapeutics covering pyrrole compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions, and methods of treating diseases and conditions. The patent names inventors Sandrine Vendeville, David Bernard Smith, Leonid Beigelman, and Vladimir Serebryany. The application was filed August 22, 2023, with 2 claims granted.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent US12599582B2 to Aligos Therapeutics for pyrrole compounds of Formula (I) and related pharmaceutical compositions. The patent covers methods of synthesizing these compounds and methods of treating diseases and conditions using them.

Competitors developing pyrrole-based therapeutics should note that Aligos now holds exclusive rights to these compounds, potentially requiring licensing negotiations or design-around strategies. The patent's issuance strengthens Aligos' intellectual property portfolio in the pharmaceutical compounds space.

What to do next

  1. Monitor patent maintenance deadlines
  2. Evaluate licensing opportunities

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Pyrrole compounds

Grant US12599582B2 Kind: B2 Apr 14, 2026

Assignee

Aligos Therapeutics, Inc.

Inventors

Sandrine Vendeville, David Bernard Smith, Leonid Beigelman, Vladimir Serebryany

Abstract

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

CPC Classifications

C07D 207/34 C07D 405/12

Filing Date

2023-08-22

Application No.

18453887

Claims

2

View original document →

Named provisions

Pyrrole compounds Pharmaceutical compositions Treatment methods

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12599582B2

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent granting Drug compound IP
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!